Premium
Liver function tests in pre‐eclampsia: importance of comparison with a reference range derived for normal pregnancy
Author(s) -
Girling J. C.,
Dow E.,
Smith J. H.
Publication year - 1997
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/j.1471-0528.1997.tb11054.x
Subject(s) - medicine , aspartate transaminase , eclampsia , pregnancy , liver function tests , reference range , gestation , preeclampsia , liver function , prospective cohort study , creatinine , obstetrics , alanine transaminase , proteinuria , gestational age , gastroenterology , gestational hypertension , bilirubin , kidney , alkaline phosphatase , biology , genetics , enzyme , biochemistry
Objectives To determine reference ranges for liver function tests in uncomplicated pregnancy and to relate abnormal results by these criteria to outcome in pre‐eclampsia. Design Prospective, cross‐sectional study to establish the reference ranges. Prospective observational study of women with pre‐eclampsia. Setting Antenatal clinics and obstetric unit of St Mary's Hospital, London. Participants Four hundred and thirty women with uncomplicated pregnancies and 85 consecutive women with gestational hypertension. Main outcome measures Aspartate transaminase (AST), alanine transaminase (ALT), bilirubin and gamma glutamyl transferase (GGT) were measured to determine their ranges in normal pregnancy. The severity of pre‐eclampsia was determined by the maximum blood pressure, creatinine and 24 h urinary protein; minimum platelet count; maternal complications; mode of and gestation at delivery; and fetal outcome with centile weight adjusted for gestational age and sex. Results AST, ALT, bilirubin and GGT were each lower in uncomplicated pregnancy than the nonpregnant laboratory reference ranges. Of those cases with elevated liver function tests in the pre‐eclampsia group, 37% were abnormal only by the new reference ranges. Using the new ranges, the prevalence of elevated liver function tests was significantly higher in the pre‐eclampsia group (54%) than in those with pregnancy induced hypertension (14%) ( P < 0.01 ). Amongst those with pre‐eclampsia, abnormal liver function tests were associated with greater proteinuria (P < 0.05), lower platelet count (P < 0.001) and more maternal complications (P < 0.01) than normal liver function tests; there was no difference in the severity of hypertension between the groups. Conclusions Liver function tests are lower in normal pregnancy than the reference ranges currently used. Our pregnancy‐derived ranges allow more precise identification of abnormal liver function in women with pre‐eclampsia than is possible using standard reference ranges derived from a nonpregnant population.